Partecipazione Italiana ed Opportunità per il Tema Salute nel Programma NMBP

29  Download (0)

Full text

(1)

Partecipazione Italiana ed Opportunità

per il Tema Salute nel Programma NMBP

Donata Medaglini

Università degli Studi di Siena

Rappresentante Italiano nel Comitato di Programma H2020

“Nanotechnologies and Advanced Materials, Biotechnology, Advanced

Manufacturing and Processing”

(SC1) Health, demographic change and well-being:

Giornata Nazionale di Lancio dei Bandi NMBP 2016-17 in Horizon 2020

(2)
(3)

KETs: Key Enabling Technologies

•Six strategic technologies

•Driving competitiviness and growth opportunities

•Contribution to solving societal challenges

•Knowledge and capital intensity

•Cut across many sectors

The relevant topics of the work programme have been

developed identifying promising areas for cross-cutting KETs.

P

h

o

to

n

ic

s

N

an

o

tec

h

n

o

lo

gy

B

io

tec

h

n

o

lo

gy

A

d

va

n

ce

d

M

ater

ia

ls

M

ic

ro

a

n

d

N

an

o

ele

ctr

o

n

ic

s

Advanced

Manufactoring Systems

European KET Strategy:

•EC Communications

(2009) 512 & (2012) 341

(4)
(5)
(6)

H2020

Technology Transfer Success as a New product Product Launch Commercialization Success as a business Research Development

L

o

s

s

e

s

/P

ro

fi

t

Time

Valley of Death

(7)

 LEIT KETs: TRLs 3 – 7; centre at TRL 5

(8)

Budget/ Calls 2014-2015

NMP

49,2%

Total Budget 2014-2015 : 992,2 € million

Budget 2014: 485,52 € million

Budget 2015: 504 € million

Budget Calls NMBP 2014-2015

1 2 3 4 5 6 BIOTECH 7,9% Sustainable Process Industries 13,5% Energy Efficient Buildings 11,5% Contributions to other programme (ICT/WASTE) 1,8% Factories of the Future 16%

NMP

49,2%

(9)

RISULTATI

NMBP CALLS 2014

9

Calls

H2020-SPIRE-2014

H2020-FoF-2014

H2020-EeB-2014

H2020-NMP-2014-two-stage

H2020-NMP-PILOTS-2014

H2020-NMP-CSA-2014

H2020-NMP-GV-2014

H2020-LEIT-BIO-2014-1

H2020-SILC-II-2014

9 calls, 40 topics

Budget 485.52 M€

96 projects retained for

funding

(10)

No. Partecipanti italiani in proposte presentate No. Partecipanti italiani finanziati Tasso di successo partecipanti Italiani

813

122

15%

No. Proposte presentate a coordinamento italiano No. Coordinamenti italiani finanziati Tasso di successo coordinatori Italiani

76

11

14,5%

Partecipazione

Coordinamento

Contributo finanziario per l’Italia

48.03 M €

(~10% del budget totale )

~

13% Progetti finanziati sono a Coordinamento Italiano

No. proposte presentate No. Proposte finanziate Tasso medio di successo

603

96

16%

Risultati 2014 NMBP

(tasso medio di successo del programma NMBP: 8%)

(11)

11

Calls 2014 NMBP

2 1 ,4 5 1 7 ,0 3 9 7 ,0 8 4 ,3 6 10,9 9 6 4 ,1 8 1 1 ,2 6 4 9 ,4 2 9 ,8 7 4 8 ,0 3 1 ,4 6 3 9 ,5 5 5 ,4 7 1 6 ,3 8 4 9 ,2 8 1 ,2 3 0 ,7 0 2 ,0 5 0 ,2 2 0 ,5 4 1 ,1 5 0 ,0 8 0 ,8 4 0 ,0 0 5,91 0 ,4 8 7,9 6 0 ,0 1 0 ,0 0 4 ,6 0 3 ,4 1 1 ,7 3 0 ,0 0 6,78 1 ,4 0 0 ,6 1 €- €20 €40 €60 €80 €100 €120 AT BE DE DK EL ES FI FR IE IT LU NL PT SE UK BG CY CZ EE HR HU LT LV MT PL RO SI SK BR CH IL IS MXNO TR US

EU15 EU13 OTH

EC Funding (M€)

(12)

12

NMP- two stage -Results 2014 Calls

12

IT Participants Success Rate: ~ 29 % (selezionate/presentate)

IT Coordinators Success Rate: ~57 % (selezionate/presentate)

Funding to Italy:

~ 14.3% of EU funding

€- €5.000.000 €10.000.000 €15.000.000 €20.000.000 €25.000.000 AT BGCHCZDK EL FI HR IE IT LU MT NL PL RO SI TR US

EC funding by country

(13)

SME Instrument Phase 1

(14)

14

10 topics

Call budget 148.370.000 €

Eligible proposals: 467

Requested EC funding 3.028.423.780 €

Average size 6,484,847 €

90 above thresholds proposals (GO)

Requesting 625,410,847€ EC funding

Indicative success rate for 2

nd

stage: 23.7%

(15)

15

H2020-NMP-2015-two-stage

Topics

NMP-11-2015 Nanomedicine therapy for cancer

NMP-12-2015 Biomaterials for treatment and prevention of Alzheimer’s disease

NMP-15-2015 Materials innovations for the optimisation of cooling in power plants

NMP-16-2015 Extended in-service life of advanced functional materials in energy technologies (capture, conversion, storage and/or transmission of energy)

NMP-19-2015 Materials for severe operating conditions, including added-value functionalities NMP-22-2015 Fibre-based materials for non-clothing applications

NMP-23-2015 Novel materials by design for substituting critical elements

NMP-24-2015 Low-energy solutions for drinking water production – pilot plants NMP-29-2015 Increasing the capacity to perform nano-safety assessment NMP-30-2015 Next generation tools for risk governance of Nanomaterials

(16)

16

H2020-NMP-2015-two-stage

Preliminary results

TOPICS

Eligible proposals

Go proposals

nb

Requested

EC funding

nb

Requested

EC funding

NMP-11-2015 63 468,871,420 12 (1 coord. IT) 97,900,000 NMP-12-2015 33 213,140,488 7 ( 1 coord IT) 49,371,800 NMP-15-2015 5 40,814,372 2 (1 coord IT) 16,000,000 NMP-16-2015 29 218,474,242 8 (1 coord IT) 65,350,370 NMP-19-2015 92 608,578,644 14 (3 coord IT) 102,624,976 NMP-22-2015 125 840,099,897 21 (2 coord IT) 138,594,667 NMP-23-2015 69 284,957,073 10 (5 coord IT) 45,511,105 NMP-24-2015 22 149,102,990 7 45,403,875 NMP-29-2015 23 160,009,978 7 48,732,986 NMP-30-2015 6 44,374,676 2 15,921,068 Total 467 3,028,423,780 90 (14 coord IT) 625,410,847

(17)

NMBP Work Programme

2016-2017

(18)

NMBP Work Programme 2016-2017

Draft WP to PC 1st March 2015 2nd May 2015 Revised Draft WP PC Opinion 14 July2015 Adoption WP October 2017 Strategic Document

Calls

2016-2017

Opening 15 October 2015 First deadline 8 December 2015

Feedback from PC

PC Approval WP

Pre-Publication Draft WP September 2015

(19)

Pre-pubblication NMBP Work programme on

Horizon 2020 website

(20)

Budget/ Calls 2014-2015

NMP

49,2%

Total Budget 2016-2017 : 966,9 € million

Budget 2016: 447,2 € million

Budget 2017: 519,7€ million

Calls NMBP 2016-2017:Budget

1 2 3 4 5 6 BIOTECH Sustainable Process Industries 13,65% Energy Efficient Buildings 10.3% Factories of the Future 15%

NMP

60% of the budget for NMBP Calls

39% of the Budget for PPP

(21)

CALLS FOR NANOTECHNOLOGIES

ADVANCED MATERIALS

(22)

ADVANCED MATERIALS AND NANOTECHNOLOGIES FOR HEALTHCARE

Year Topic Topic Title Instrument TRL Deadline

2016

NMBP 09-2016 Biomaterials for diagnosis and treatment of

demyelination disorders of the Central Nervous System RIA 3-5 1st Stage: 8/12/15

2nd Stage:24/5/16

NMBP 10-2016 Nanoformulation of biologicals RIA 3/4-5/6 NMBP 11-2016 ERA-NET on Nanomedicine ERA-NET

cofund 21/1/16

2017

NMBP 12-2017

Development of a reliable methodology for better risk management of engineered biomaterials in Advanced Therapy Medicinal Products and/or Medical Devices

RIA 4-6 12stnd Stage: 27/10/16 Stage: 4/5/17

NMBP 13-2017 Cross-cutting KETs for diagnostics at the point-of-care RIA 3/4-5/6 19/1/17 NMBP 14-2017 Regulatory Science Framework for assessment of risk

benefit ratio of Nanomedicines and Biomaterials IA 5-6

1st Stage: 27/10/16

2nd Stage: 4/5/17

NMBP 15-2017 Nanotechnologies for imaging cellular transplants and

regenerative processes in vivo RIA 3/4-5/6

1st Stage: 27/10/16

2nd Stage: 4/5/17

(23)

BIOTECHNOLOGY

Year Topic Topic Title Instrument TRL Deadline

2016

BIOTEC-01-2016 ERA-NET Cofund on Biotechnologies ERA-NET

Cofund 3-6 21/1/16 BIOTEC-02-2016 Bioconversion of non-agricultural waste into

biomolecules for industrial applications RIA 3-5

1st Stage: 8/12/15

2nd Stage: 24/5/16

BIOTEC-03-2016

Microbial chassis platforms with optimized metabolic pathways for industrial innovations through systems biology

RIA 3-5 BIOTEC-04-2016 KET Biotechnology foresight identifying gaps and

high-value opportunities for the EU industry CSA 21/1/16

2017

BIOTEC-05-2017 Microbial platforms for CO2-reuse processes in the

low-carbon economy RIA 3-5

1st Stage: 27/10/16

2nd Stage: 4/5/17

BIOTEC-06-2017

Optimisation of biocatalysis and downstream processing for the sustainable production of high value-added platform chemicals

IA 5-7 BIOTEC-07-2017 New Plant Breeding Techniques (NPBT) in molecular

farming: Multipurpose crops for industrial bioproducts RIA 3-5 BIOTEC-08-2017 Support for enhancing and demonstrating the impact of

(24)

MODELLING FOR THE DEVELOPMENT OF NANOTECHNOLOGIES AND

ADVANCED MATERIALS

Year Topic Topic Title Instrument TRL Deadline

2016

NMBP-23-2016

Advancing the integration of Materials Modelling in Business Processes to enhance effective industrial decision making and increase competitiveness

RIA 5 21ndst Stage: 8/12/15 Stage:24/5/16

NMBP-24-2016

Network to capitalise on strong European position in materials modelling and to allow industry to reap the benefits

CSA 21/1/16

2017 NMBP-25-2017

Next generation system integrating tangible and intangible materials model components to support innovation in industry

IA 6 1

st Stage: 27/10/16

(25)

SCIENCE-BASED RISK ASSESSMENT AND MANAGEMENT OF

NANOTECHNOLOGIES, ADVANCED MATERIALS AND BIOTECHNOLOGIES

Year Topic Topic Title Instrument TRL Deadline

2016

NMBP-26-2016 Analytical techniques and tools in support of

nanomaterial risk assessment RIA 5-6

1st Stage: 8/12/15

2nd Stage:24/5/16

NMBP-27-2016

Promoting safe innovation through global consolidation and networking of nanosafety centres and

strengthening the European industry through cooperation in nanosafety

CSA 21/1/16

2017

NMBP-28-2017

Framework and strategies for nanomaterial

characterisation, classification, grouping and read-across for risk analysis

RIA 5-7

1st Stage: 27/10/16

2nd Stage: 4/5/17

NMBP-29-2017 Advanced and realistic models and assays for

(26)

SME INSTRUMENT

Year Topic Topic Title Instrument TRL

2016 2017

SMEInst-02-2016-2017

Accelerating the uptake of nanotechnologies advanced materials or advanced manufacturing and processing technologies by SMEs SMEInst 2016 2017 SMEInst-03-2016-2017

Dedicated support to biotechnology SMEs closing the gap from

(27)

PILOTS

Year Topic Topic Title Instrument TRL Deadline

2016

PILOTS-01-2016 Pilot lines for manufacturing of materials with

customized thermal/electrical conductivity properties IA

4/6, target 7

1st Stage: 8/12/15

2nd Stage: 24/5/16

PILOTS-02-2016

Pilot Line Manufacturing of Nanostructured Antimicrobial Surfaces using Advanced Nanosurface Functionalization Technologies

IA 4/6,

target 7

2017

PILOTS-03-2017 Pilot Lines for Manufacturing of Nanotextured surfaces

with mechanically enhanced properties IA

4/6, target 7

1st Stage: 27/10/16

2nd Stage: 4/5/17

PILOTS-04-2017 Pilot Lines for 3D printed and/or injection moulded

polymeric or ceramic microfluidic MEMS IA

4/6, target 7 PILOTS-05-2017 Paper-based electronics RIA 3,

(28)

Donata Medaglini

Rappresentante Italiana per il Comitato NMBP in H2020

Esperti:

Elisa Molinari

CNR NANO, Università di Modena e Reggio Emilia

Rappresentante IT nel Comitato NMP in FP7

Luisa Tondelli

CNR Bologna

Luisa Torsi

Università di Bari

Ministero dello Sviluppo Economico

Confindustria

(29)

Martina De Sole

desole@apre.it

Serena Borgna

borgna@apre.it

Figure

Updating...

References

Related subjects :